Results 151 to 160 of about 23,186 (272)

Fenfluramine: An Uncommon Cause of False Positive Urine Drug Testing: A Case Report

open access: yesAnnals of the Child Neurology Society, Volume 3, Issue 2, Page 121-124, June 2025.
ABSTRACT Background Fenfluramine is an antiseizure medication approved by the Food and Drug Administration for the treatment of Dravet syndrome in patients older than 2 years. Fenfluramine is an amphetamine derivative. It cross‐reacts with amphetamines in urine drug screen immunoassays. Patient Presentation A 2‐year‐old patient with Dravet syndrome had 
Maria Ghawji   +2 more
wiley   +1 more source

Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates

open access: yesEpilepsia Open, Volume 10, Issue 3, Page 948-956, June 2025.
Abstract To study the relationship between the delay in treatment and the efficacy of phenobarbital in neonates, we re‐analyzed data from the NEOLEV2 study. Continuous video EEG (cEEG) from patients treated with phenobarbital was reviewed by neurophysiologists who marked each seizure.
Cynthia Sharpe   +9 more
wiley   +1 more source

A Possible Role of the Thalamus in Some Cases of Sudden Unexpected Death in Epilepsy [PDF]

open access: bronze, 2007
Fúlvio A. Scorza   +4 more
openalex   +1 more source

The Insula and Its Epilepsies [PDF]

open access: yes, 2019
Insular seizures are great mimickers of seizures originating elsewhere in the brain. The insula is a highly connected brain structure. Seizures may only become clinically evident after ictal activity propagates out of the insula with semiology that ...
Gonzalez-Martinez, Jorge   +8 more
core   +1 more source

Cardiac structural and molecular alterations in rodent models of temporal lobe epilepsy

open access: yesEpilepsia Open, Volume 10, Issue 3, Page 809-821, June 2025.
Abstract Objective Cardiac structural and molecular changes are prevalent in people with chronic epilepsy, possibly contributing to an increased risk of premature mortality. However, understanding of the underlying pathophysiological mechanisms is limited.
Zining Liu   +9 more
wiley   +1 more source

Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?

open access: yesEpilepsy and Behavior Case Reports, 2019
Mortality associated with cannabis used for treatment of epilepsy is not well documented. We discuss two fatalities in the setting of epilepsy and self-determined therapy with cannabis (SDTC). One patient had probable sudden unexpected death in epilepsy,
Devon M. Kollmyer   +3 more
doaj  

Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic–clonic seizures

open access: yesEpilepsia Open, Volume 10, Issue 3, Page 880-893, June 2025.
Abstract Objective Evaluating the efficacy of an opioid antagonist, naloxone (NLX), to reduce the severity of post‐ictal hypoxemia and immobility after focal to bilateral tonic–clonic seizures (FBTCS). Methods ENALEPSY is a double‐blind placebo (PCB)‐controlled trial conducted in patients with focal epilepsy undergoing long‐term video‐EEG monitoring ...
Sylvain Rheims   +71 more
wiley   +1 more source

Home - About - Disclaimer - Privacy